Deutsch English Français

Contact

EP0708592

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0708592

EP0708592 - MTS GENE, MUTATIONS THEREIN, AND METHODS FOR DIAGNOSING CANCER USING MTS GENE SEQUENCE [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 28.06.2002 Database last updated on 13.11.2024
Most recent event Tooltip	28.06.2002	Application deemed to be withdrawn	published on 14.08.2002 [2002/33]
Applicant(s)	For all designated states MYRIAD GENETICS, INC. 390 Wakara Way Salt Lake City Utah 84108 / US
	[N/P]
Former [1996/18]	For all designated states MYRIAD GENETICS, INC. 390 Wakara Way Salt Lake City, Utah 84108 / US
Inventor(s)	01 / KAMB, Alexander 1103 East 600 South Salt Lake City, UT 84102 / US
	[1996/18]
Representative(s)	Irvine, Jonquil Claire J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
	[N/P]
Former [1996/18]	Irvine, Jonquil Claire J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5LX / GB
Application number, filing date	95914738.0	17.03.1995
	[1996/18]
	WO1995US03316
Priority number, date	US19940214581	18.03.1994 Original published format: US 214581
	US19940214582	18.03.1994 Original published format: US 214582
	US19940215088	18.03.1994 Original published format: US 215088
	US19940227369	14.04.1994 Original published format: US 227369
	US19940251938	01.06.1994 Original published format: US 251938
	[1996/18]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9525429
	Date:	28.09.1995
	Language:	EN
	[1995/41]
	Type:	A1 Application with search report
	No.:	EP0708592
	Date:	01.05.1996
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 28.09.1995 takes the place of the publication of the European patent application.
	[1996/18]
Search report(s)	International search report - published on:	US	28.09.1995
	(Supplementary) European search report - dispatched on:	EP	19.03.1997
Classification	IPC:	C12N15/12, C07K14/47, C12Q1/68, C07H21/04, C07H21/02, G01N33/53, A61K48/00, A01K67/027	[1997/17]
	CPC:	C07K14/4703 (EP); A61P35/00 (EP); A01K2217/05 (EP); A61K38/00 (EP); A61K48/00 (EP)
	Former IPC [1996/18]	A01K67/00, A61K48/00, C07H21/00, C07K14/435, C07K16/00, C12N1/21, C12N15/09, C12N15/12
Designated contracting states	AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1996/18]
Title	German:	MTS-GEN, MUTATIONEN DARIN UND METHODEN ZUR KREBSDIAGNOSTIK MITTELS DER MTS-GENSEQUENT	[1996/18]
	English:	MTS GENE, MUTATIONS THEREIN, AND METHODS FOR DIAGNOSING CANCER USING MTS GENE SEQUENCE	[1996/18]
	French:	GENE MTS, MUTATIONS DESDITS GENES ET PROCEDES DE DIAGNOSTIC DU CANCER A L'AIDE DE SEQUENCES DU GENE MTS	[1996/18]
Entry into regional phase	20.11.1995	National basic fee paid
	20.11.1995	Search fee paid
	20.11.1995	Designation fee(s) paid
	20.11.1995	Examination fee paid
Examination procedure	20.11.1995	Examination requested [1996/18]
	10.07.2001	Despatch of a communication from the examining division (Time limit: M06)
	22.01.2002	Application deemed to be withdrawn, date of legal effect [2002/33]
	12.03.2002	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2002/33]
Fees paid	Renewal fee
	24.03.1997	Renewal fee patent year 03
	26.03.1998	Renewal fee patent year 04
	04.03.1999	Renewal fee patent year 05
	06.03.2000	Renewal fee patent year 06
	08.03.2001	Renewal fee patent year 07
	Penalty fee
	Additional fee for renewal fee
	31.03.2002	08 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]WO9200757 (RES CORP TECHNOLOGIES INC [US]) [X] 1,25,28-31,34-36,84,91 * claims 1-44 *;
		[PX]WO9409135 (COLD SPRING HARBOR LAB [US]) [PX] 1,5-8,15-18,23,25,28-36,41-49 * the whole document *;
		[T]WO9528169 (UNIV CALIFORNIA [US]) [T] 7,10,15,28-31,34-44,84 * figure SEQ.ID.2; claims 1-38 *;
		[T]WO9528483 (COLD SPRING HARBOR LAB [US]) [T] 1-3,5-8,15-17,28-33,36-44,53,65-72 * figure SEQ.ID.1; claims 1-56 *
		[X] - SERRANO M ET AL, "A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4", NATURE, DEC 16 1993, 366 (6456) P704-7, ENGLAND, XP002026854 [X] 1,5-8,15,28-33 * the whole document * DOI: http://dx.doi.org/10.1038/366704a0
		[PX] - KAMB A ET AL, "A cell cycle regulator potentially involved in genesis of many tumor types [see comments]", SCIENCE, APR 15 1994, 264 (5157) P436-40, UNITED STATES, XP002026855 [PX] 1-3,5-8,15-17,28-33,36-44,53,65-72 * the whole document * DOI: http://dx.doi.org/10.1126/science.8153634
		[PX] - HANNON GJ ET AL, "p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest [see comments]", NATURE, SEP 15 1994, 371 (6494) P257-61, ENGLAND, XP002026856 [PX] 1,3,5-8,13,15,28-33 * the whole document * DOI: http://dx.doi.org/10.1038/371257a0
		[PX] - OKAMOTO A ET AL, "Mutations and altered expression of p16INK4 in human cancer.", PROC NATL ACAD SCI U S A, NOV 8 1994, 91 (23) P11045-9, UNITED STATES, XP002026857 [PX] 1-3,5-8,15-17,28-33,36-44,53,65-72 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.91.23.11045
		[PX] - JEN J ET AL, "Deletion of p16 and p15 genes in brain tumors.", CANCER RES, DEC 15 1994, 54 (24) P6353-8, UNITED STATES, XP002026858 [PX] 1-3,5-8,15-17,28-33,36-44,53,65-72 * the whole document *
	International search	[XPY] - SCIENCE, Volume 264, issued 15 April 1994, KAMB et al.: "A cell cycle regulator potentially involved in genesis of many tumor types", pages 436-440, see the entire document.
		[XY] - NATURE, Volume 366, issued 16 December 1993, SERRANO et al.: "A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4", pages 704-707, see the entire document.
		[Y] - A. JOHNSTONE et al.: "Immunochemistry in Practice", published 1987 by BLACKWELL SCIENTIFIC PUBLICATIONS (Oxford), pages 30-47, see the entire document.
		[Y] - SCIENCE, Volume 240, issued 10 June 1988, JAENISCH, "Transgenic animals", pages 1468-1474, see the entire document.
		[Y] - SCIENCE, Volume 254, issued 22 November 1991, ADAMS et al.: "Transgenic models of tumor development", pages 1161-1167, see the entire document.

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p